Lynoral - Lynoral, the principal intracellular human estrogen, is substantially more active than its metabolites, estrone and estriol, at the cellular level.
Indication: For the treatment of urogenital symptoms associated with post-menopausal atrophy of the vagina (such as dryness, burning, pruritus and dyspareunia) and/or the lower urinary tract (urinary urgency and dysuria).
Lynoral also ethinyl estradiol (EE), is a derivative of estradiol. Ethinyl estradiol is an orally bio-active estrogen used in almost all modern formulations of combined oral contraceptive pills (the Pill). It is one of the most commonly used medications.
The same contraindications and precautions apply for EE as with other estrogen medications.
Estinyl was a preparation of EE alone that was used for the management of menopausal symptoms and female hypogonadism.
EE is released into the environment as a xenoestrogen from the urine and feces of people who take it as a medication.
Indications: menstrual disorders, breast cancer
HRT,Female hypogonadism,Palliative treatment of breast carcinoma,Palliative treatment of prostatic carcinoma,As part of combined oral contraceptive.